Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market Size Is Poised To Reach USD 3.4 Billion By 2025 : Grand View Research Inc.
San Francisco, 11 September 2019: The Report Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market A nalysis By Therapy (Chemotherapy, Hyper-CVAD, Linker Regimen, Targeted Therapy, Radiation Therapy), And Segment Forecasts, 2018 – 2025 The global acute lymphocytic/lymphoblastic leukemia therapeutics market is expected to reach USD 3.4 billion by 2025, according to a new report by Grand View Research, Inc. Increasing public and private initiatives for diagnosis of Acute Lymphoblastic Leukemia (ALL), rising number of bone marrow biopsies, and availability of other treatment options are factors expected to increase the adoption of ALL procedures. For instance, The Baby Friendly Initiative Program by UNICEF (UK) and SickKids-Caribbean Initiative, a collaborative approach between hospitals and healthcare institutions in Canada, aim to provide free diagnosis and treatment services to infants suffering from ALL, who meet certain eligibility criteria. Furthermore, rising incid